Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 

QPP Measure #PIMSH20

Appropriate Antiemetic Therapy for High- and Moderate-Emetic-Risk Antineoplastic Agents

Percentage of cancer patients aged 18 years and older treated with high- or moderate-emetic-risk antineoplastic agents who are administered appropriate pre-treatment antiemetic therapy

Submission Methods: Registry

There are no codes for this QPP measure yet (code lists for the current year may not have been established yet).

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.